Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia
Identifieur interne : 004867 ( Istex/Curation ); précédent : 004866; suivant : 004868Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia
Auteurs : Harriet Holme [Royaume-Uni] ; Upal Hossain [Royaume-Uni] ; Michael Kirwan [Royaume-Uni] ; Amanda Walne [Royaume-Uni] ; Tom Vulliamy [Royaume-Uni] ; Inderjeet Dokal [Royaume-Uni]Source :
- British Journal of Haematology [ 0007-1048 ] ; 2012-07.
Abstract
The myelodysplastic syndromes (MDS) are heterogeneous and can evolve into acute myeloid leukaemia (AML). Rare familial cases are reported in which five disease genes have been identified to date (RUNX1, CEBPA, TERC, TERT and GATA2). Here we report the genetic categorization of 27 families with familial MDS/AML. All of these families were screened for RUNX1, CEBPA, TERC, TERT and GATA2 as well as TET2 and NPM1. Five of the 27 families had telomerase mutations; one had a RUNX1 mutation, while none were found to have TET2, CEBPA or NPM1 mutations. We identified four families with heterozygous GATA2 mutations, each associated with a different phenotype. While one of these mutations is novel, three have been previously reported: one has been described in dendritic cell, monocyte, B and NK lymphoid (DCML) deficiency and one is in a family that has been reported in a series with primary lymphoedema with a predisposition to AML (Emberger syndrome). In summary, genetic characterization was shown in 10 (four GATA2, three TERT, two TERC, one RUNX1) of these families; however 17 remain uncharacterized, highlighting marked genetic heterogeneity in familial MDS/AML and the scope for further functional pathways that could give rise to this group of disorders.
Url:
DOI: 10.1111/j.1365-2141.2012.09136.x
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004867
Links to Exploration step
ISTEX:9A46D7B6A42E05DE86919535DE67234CC52DE16DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia</title><author><name sortKey="Holme, Harriet" sort="Holme, Harriet" uniqKey="Holme H" first="Harriet" last="Holme">Harriet Holme</name><affiliation wicri:level="1"><mods:affiliation>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London</wicri:regionArea></affiliation><affiliation><mods:affiliation>Correspondence: Dr Harriet Holme, Centre for Paediatrics, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AT, UK.E‐mail:</mods:affiliation><wicri:noCountry code="subField">UK.E‐mail:</wicri:noCountry></affiliation><affiliation><mods:affiliation>E-mail: harrietholme@hotmail.com</mods:affiliation><wicri:noCountry code="no comma">E-mail: harrietholme@hotmail.com</wicri:noCountry></affiliation></author><author><name sortKey="Hossain, Upal" sort="Hossain, Upal" uniqKey="Hossain U" first="Upal" last="Hossain">Upal Hossain</name><affiliation wicri:level="1"><mods:affiliation>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London</wicri:regionArea></affiliation></author><author><name sortKey="Kirwan, Michael" sort="Kirwan, Michael" uniqKey="Kirwan M" first="Michael" last="Kirwan">Michael Kirwan</name><affiliation wicri:level="1"><mods:affiliation>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London</wicri:regionArea></affiliation></author><author><name sortKey="Walne, Amanda" sort="Walne, Amanda" uniqKey="Walne A" first="Amanda" last="Walne">Amanda Walne</name><affiliation wicri:level="1"><mods:affiliation>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London</wicri:regionArea></affiliation></author><author><name sortKey="Vulliamy, Tom" sort="Vulliamy, Tom" uniqKey="Vulliamy T" first="Tom" last="Vulliamy">Tom Vulliamy</name><affiliation wicri:level="1"><mods:affiliation>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London</wicri:regionArea></affiliation></author><author><name sortKey="Dokal, Inderjeet" sort="Dokal, Inderjeet" uniqKey="Dokal I" first="Inderjeet" last="Dokal">Inderjeet Dokal</name><affiliation wicri:level="1"><mods:affiliation>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:9A46D7B6A42E05DE86919535DE67234CC52DE16D</idno><date when="2012" year="2012">2012</date><idno type="doi">10.1111/j.1365-2141.2012.09136.x</idno><idno type="url">https://api.istex.fr/document/9A46D7B6A42E05DE86919535DE67234CC52DE16D/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004867</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">004867</idno><idno type="wicri:Area/Istex/Curation">004867</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia</title><author><name sortKey="Holme, Harriet" sort="Holme, Harriet" uniqKey="Holme H" first="Harriet" last="Holme">Harriet Holme</name><affiliation wicri:level="1"><mods:affiliation>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London</wicri:regionArea></affiliation><affiliation><mods:affiliation>Correspondence: Dr Harriet Holme, Centre for Paediatrics, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AT, UK.E‐mail:</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: harrietholme@hotmail.com</mods:affiliation></affiliation></author><author><name sortKey="Hossain, Upal" sort="Hossain, Upal" uniqKey="Hossain U" first="Upal" last="Hossain">Upal Hossain</name><affiliation wicri:level="1"><mods:affiliation>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London</wicri:regionArea></affiliation></author><author><name sortKey="Kirwan, Michael" sort="Kirwan, Michael" uniqKey="Kirwan M" first="Michael" last="Kirwan">Michael Kirwan</name><affiliation wicri:level="1"><mods:affiliation>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London</wicri:regionArea></affiliation></author><author><name sortKey="Walne, Amanda" sort="Walne, Amanda" uniqKey="Walne A" first="Amanda" last="Walne">Amanda Walne</name><affiliation wicri:level="1"><mods:affiliation>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London</wicri:regionArea></affiliation></author><author><name sortKey="Vulliamy, Tom" sort="Vulliamy, Tom" uniqKey="Vulliamy T" first="Tom" last="Vulliamy">Tom Vulliamy</name><affiliation wicri:level="1"><mods:affiliation>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London</wicri:regionArea></affiliation></author><author><name sortKey="Dokal, Inderjeet" sort="Dokal, Inderjeet" uniqKey="Dokal I" first="Inderjeet" last="Dokal">Inderjeet Dokal</name><affiliation wicri:level="1"><mods:affiliation>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London Children's Hospital, London</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">British Journal of Haematology</title><title level="j" type="alt">BRITISH JOURNAL OF HAEMATOLOGY</title><idno type="ISSN">0007-1048</idno><idno type="eISSN">1365-2141</idno><imprint><biblScope unit="vol">158</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="242">242</biblScope><biblScope unit="page" to="248">248</biblScope><biblScope unit="page-count">7</biblScope><date type="published" when="2012-07">2012-07</date></imprint><idno type="ISSN">0007-1048</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0007-1048</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The myelodysplastic syndromes (MDS) are heterogeneous and can evolve into acute myeloid leukaemia (AML). Rare familial cases are reported in which five disease genes have been identified to date (RUNX1, CEBPA, TERC, TERT and GATA2). Here we report the genetic categorization of 27 families with familial MDS/AML. All of these families were screened for RUNX1, CEBPA, TERC, TERT and GATA2 as well as TET2 and NPM1. Five of the 27 families had telomerase mutations; one had a RUNX1 mutation, while none were found to have TET2, CEBPA or NPM1 mutations. We identified four families with heterozygous GATA2 mutations, each associated with a different phenotype. While one of these mutations is novel, three have been previously reported: one has been described in dendritic cell, monocyte, B and NK lymphoid (DCML) deficiency and one is in a family that has been reported in a series with primary lymphoedema with a predisposition to AML (Emberger syndrome). In summary, genetic characterization was shown in 10 (four GATA2, three TERT, two TERC, one RUNX1) of these families; however 17 remain uncharacterized, highlighting marked genetic heterogeneity in familial MDS/AML and the scope for further functional pathways that could give rise to this group of disorders.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004867 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 004867 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:9A46D7B6A42E05DE86919535DE67234CC52DE16D
|texte= Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia
}}
| This area was generated with Dilib version V0.6.31. |  |